Professor, Psychiatry, UCLA School of Medicine
Psychiatry
Dr. Helen Lavretsky, MD
|
|
Give Review
Helen Lavretsky works in the field of Psychiatry. He has 3 awards "Fellow", "Top 10 papers in Psychiatry 2015" and "Distinguished Fellow". Helen Lavretsky is also published. He has 67 publications published. The lastest publication: "The Russian concept of schizophrenia: a review of the literature.' Helen Lavretsky accepts all Medicare patients.
Publications
- Natural products and supplements for geriatric depression and cognitive Disorders: an evaluation of the research.
- Feasibility of Central Meditation and Imagery Therapy for dementia caregivers.
- The Patterns of Cognitive and Functional Impairment in Amnestic and Non-amnestic Mild Cognitive Impairment in Geriatric Depression.
- An Observational Study of the Health Benefits of Yoga or Tai Chi Compared With Aerobic Exercise in Community-Dwelling Middle-Aged and Older Adults.
- Psychological Well-Being and Regional Brain Amyloid and Tau in Mild Cognitive Impairment.
- Vascular Risk and FDDNP-PET Influence Cognitive Performance.
- A pilot study of yogic meditation for family dementia caregivers with Depressive symptoms: effects on mental health, cognition, and telomerase activity.
- A pilot study of the effects of meditation on regional brain metabolism in distressed dementia caregivers.
- Stress, Inflammation, and Aging.
- Yogic meditation reverses NF-κB and IRF-related transcriptome dynamics in leukocytes of family dementia caregivers in a randomized controlled trial.
- Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementia.
- Cognitive Behavioral Therapy vs. Tai Chi for Late Life Insomnia and Inflammatory Risk: A Randomized Controlled Comparative Efficacy Trial.
- Local cerebral glucose metabolism in patients with long-term behavioral and cognitive deficits following mild traumatic brain injury.
- A structured trial of risperidone for the treatment of agitation in dementia.
- Relationship of age, age at onset, and sex to depression in older adults.
- The Russian concept of Schizophrenia: a review of the literature.
- Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele.
- Clinical and neuroradiologic features associated with chronicity in late-life depression.
- Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.
- Apolipoprotein-E and white-matter hyperintensities in late-life depression.
- Volumetric asymmetries in late-onset mood Disorders: an attenuation of frontal asymmetry with depression severity.
- Estrogen use and brain metabolic change in older adults. A preliminary report.
- Methylphenidate augmentation of citalopram in elderly depressed patients.
- Memory self-appraisal and Depressive symptoms in people at genetic risk for Alzheimer''s disease.
- Frontal white matter biochemical abnormalities in late-life Major depression detected with proton magnetic resonance spectroscopy.
- Clinically significant non-Major depression: old concepts, new insights.
- Predictors of two-year mortality in a prospective "UPBEAT" study of elderly veterans with comorbid medical and psychiatric symptoms.
- MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression.
- Symptoms of depression and Anxiety predict mortality in elderly veterans enrolled in the UPBEAT program.
- Practical geriatrics: clinically significant nonMajor geriatric depression.
- Apolipoprotein epsilon4 allele status, Depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia.
- Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex.
- Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial.
- The significance of subsyndromal depression in geriatrics.
- Mapping brain size and cortical gray matter changes in elderly depression.
- Medical burden, cerebrovascular disease, and cognitive impairment in geriatric depression: modeling the relationships with the CART analysis.
- Executive dysfunction and visuospatial ability among depressed elders in a community setting.
- Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial.
- Localizing gray matter deficits in late-onset depression using computational cortical pattern matching methods.
- Sex differences in brain structure in geriatric depression.
- Estrogen use and brain metabolic change in postmenopausal women.
- Antidepressant exposure may protect against decrement in frontal gray matter volumes in geriatric depression.
- Methylphenidate-enhanced antidepressant response to citalopram in the elderly: a double-blind, placebo-controlled pilot trial.
- Innovations: geriatric psychiatry: diagnosis and treatment of neuropsychiatric symptoms in Alzheimer's disease.
- Effects of a 14-day healthy longevity lifestyle program on cognition and brain function.
- Executive dysfunction and memory in older patients with Major and minor depression.
- PET of brain amyloid and tau in mild cognitive impairment.
- Neuroanatomical characteristics of geriatric apathy and depression: a magnetic resonance imaging study.
- The effects of the dopamine and serotonin transporter polymorphisms on clinical features and treatment response in geriatric depression: a pilot study.
- The MRI brain correlates of depressed Mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia.
- Neuropsychiatric symptoms in Alzheimer disease and related Disorders: why do treatments work in clinical practice but not in the randomized trials?
- Daily functioning and prefrontal brain morphology in healthy and depressed community-dwelling elderly.
- Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study.
- Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study.
- Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.
- Differential FDDNP PET patterns in nondemented middle-aged and older adults.
- Depression and Anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.
- Therapy of depression in dementia.
- Influences of lobar gray matter and white matter lesion load on cognition and Mood.
- Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram.
- Association of depressed Mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study.
- Prior depression history and deterioration of physical health in community-dwelling older adults--a prospective cohort study.
- A tune in "a minor" can "b Major": a review of epidemiology, illness course, and public health implications of subthreshold depression in older adults.
- Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial.
- Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.
- Convergence Science Arrives: How Does It Relate to Psychiatry?
Procedures Preformed
- Electroconvulsive Therapy (ECT)
- Psychiatric Evaluation
Conditions Treated
- Adjustment Disorder
- Alcoholism (Alcohol Dependence)
- Anxiety
- Bipolar Disorder
- View All
Doctors Specialties
- Geriatric Psychiatry
- Psychiatry
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Advantage Preferred DirectAccess Plus PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select Plus HMO
- Select PPO
- Great West Healthcare-Cigna PPO
- Commercial Insurance Company
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Heritage Signature
Awards
- Fellow
- Top 10 papers in Psychiatry 2015
- Distinguished Fellow
Education
-
UCLA Medical Center -
IM Sechenov Moscow Medical Academy
Hospital
-
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1881627404 | |
| NPPES Provider LastName | LAVRETSKY | |
| NPPES Provider FirstName | HELEN | |
| NPPES Provider ZIPCode | 900958353 | |
| NPPES Provider State | CA | |
| Specialty Description | Geriatric Psychiatry | |
| Total Claim Count | 1624.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1881627404 |
| Last Name Of The Provider | LAVRETSKY |
| First Name Of The Provider | HELEN |
| View All |
Similar Doctors
|
Dr. Wendy S. Rosenstein, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Doryann M. Lebe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel A. Plotkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil Hartman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew F. Leuchter, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Martha J. Kirkpatrick, MD |
|
|
Dr. Kira A. Williams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark G. Barad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mara Blakis, MD
This Doctor is OpenDoctor Recommended.
|